Joyvié Health Raises $1M to Reinvent Continence Care

Jan de Vries · 2026-06-05

UK-based Joyvié Health has closed its pre-Seed funding round, raising a total of $1.04 million for its continence underwear. It’s designed from first principles to significantly reduce stool-to-skin contact, maintain skin integrity, and ease the burden on caregivers. ### The Funding Details The funding comes from an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and individual angel investors. That mix of public and private backing shows real confidence in the mission. “Products designed for care should never cause harm. That’s not a vision statement. It’s the reason this company exists,” says Zoe Robson, Founder & CEO of Joyvié Health.  ### A Wave of HealthTech Funding in 2026 Joyvié Health’s pre-Seed round is part of a bigger story. Across the UK and Europe, 2026 has seen a surge in HealthTech funding for care delivery, clinical workflow, elderly care, medical devices, and women’s health. Here’s a snapshot: - **In the UK:** Semble raised $40.5 million to scale its healthcare management platform for outpatient providers. Evaro secured $24.5 million to expand NHS-licensed embedded health services. JAAQ closed $17.5 million for enterprise partnerships. Calibre emerged from stealth with $3.3 million to tackle health guesswork. Nul raised $979,000 to launch its alcohol-dependence care platform. - **In Europe:** Recare in Berlin raised up to $43.1 million for its AI hospital platform. Patronus raised $12.8 million for a senior-friendly emergency smartwatch and family app. Tucuvi raised $19.8 million for voice-AI nursing follow-up automation. Ditto in Rotterdam raised $8.9 million to simplify medical information. ShanX Medtech secured $28 million for antimicrobial-resistance diagnostics, starting with women’s health in UTIs. MedVasc raised $2.6 million for its anesthesia catheter toward US approval. Taken together, these rounds amount to over $202 million in related 2026 HealthTech funding. That’s a lot of momentum. “At Lavender Ventures, we’re committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people’s lives,” says Gail Armstrong of Lavender Ventures. “We believe the market is ripe for innovation, and Joyvié’s approach has the potential to deliver significant benefits—not just for individuals, but for carers, healthcare systems, and the environment.” ### A Personal Story Behind the Mission Joyvié Health was founded by Zoe Robson after the death of her father, Fred, in 2025. Fred was 77, fit, and sharp-minded when a late-stage pancreatic cancer diagnosis arrived without warning on Christmas Eve 2024. Eleven weeks later, he was gone. In those eleven weeks, Fred lost bowel control and had to wear a nappy. Faeces trapped against skin breaks it down—moisture, pathogens, and pH imbalance do damage that never fully heals. His skin broke down. His dignity went with it, change by change. And Ruth, his wife and primary caregiver, carried a burden that was invisible to the world outside and impossibly hard to bear. “My parents didn’t deserve that,” says Zoe. “They were both at their most vulnerable—and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn’t from lack of care. It’s a design failure.” ### The Innovation: A New Approach to Continence Care Joyvié is on a mission to end the silent humiliation of faecal incontinence (FI)—a condition affecting an estimated 656 million people globally. Yet the most common non-invasive solution remains unchanged for decades: nappies and pads. Where existing products trap faeces against the skin, Joyvié contains stool in a disposable pouch immediately after excretion. This significantly reduces skin contact, preserves dignity, and cuts the time and burden of care. Early testing shows about a 90% reduction in stool-to-skin contact and about 70% faster changes. Faecal incontinence is often caused by conditions like diarrhoea, constipation, nerve damage, or muscle weakness. It can happen to anyone, but it’s especially common in elderly care, postpartum recovery, and chronic illness. The current solutions just don’t cut it. ### Why This Matters This isn’t just about a product. It’s about changing how we care for people at their most vulnerable. Joyvié’s approach could reduce pressure sores, infections, and the emotional toll on patients and families. For caregivers, it means less time cleaning and more time connecting. If you’re in the startup or HealthTech space, keep an eye on Joyvié. They’re proving that innovation driven by real human stories can create real change.